Entries by AMP

Parkinson Voice Project Going Global with Speech Therapy Grant Program

This year, Parkinson Voice Project (PVP) is broadening its SPEAK OUT! & LOUD Crowd Grant Program to include support for international speech therapy clinics. The expanded grant program is intended to help Parkinson’s disease patients around the world gain access to quality speech treatment to maintain their speaking abilities and minimize the threat of swallowing problems. In addition […]

My PD Frustration Consists of More Than Only Symptoms and Treatments

    by Jean Mellano “You don’t have to be positive all the time. It’s perfectly okay to feel sad, angry, annoyed, frustrated, scared and anxious. Having feelings doesn’t make you a ‘negative person.’ It makes you human.” –Lori Deschene As many people with Parkinson’s will attest, both Parkinson’s disease (PD) symptoms and finding the right […]

New Parkinson’s Drug Comes to Market after Early Investment from The Michael J. Fox Foundation

People with Parkinson’s have a new treatment option due in part to funding from The Michael J. Fox Foundation (MJFF). On December 21, 2018, the U.S. Food and Drug Administration approved Inbrija, an inhaled levodopa powder, for “off” episodes, when Parkinson’s symptoms are not well controlled with oral medication. MJFF supported early clinical trials of […]

Meditation and Parkinson’s Disease: Looking for Lightness of Being

Living with Parkinson’s disease is a struggle against the loss of both motor and cognitive functions. One must invest effort into an action plan that reduces the impact of the disease — a rehab plan. This effort is daily (sometimes hourly) and can be exhausting. Living with PD is like carrying a large backpack of […]

The Season of Giving

PAA is blessed to have an active, passionate, and growing support network of board members, volunteers, donors, sponsors, and thought leaders. It is because of this generous support – by people just like you – that PAA continues to fulfill and grow the promise of its mission to improve the lives of Parkinson’s patients, caregivers, […]

MJFF and Blackfynn Collaborate on Parkinson’s Study to Discover Biomarkers

The Michael J. Fox Foundation (MJFF) and Blackfynn are joining forces to make optimal use of an initiative that could uncover Parkinson’s disease biomarkers and bring about new therapies. Called the Parkinson’s Progression Markers Initiative (PPMI), the MJFF-backed effort is an ongoing observational study of more than 1,300 volunteer participants both with and without Parkinson’s […]

2018 Parkinson’s Symposium Media Archive

Our annual symposium draws PD patients, caregivers, and loved ones from all over Alabama to engage multiple thought leaders who are experts in Parkinson’s Disease research, treatment, care and other focus areas. Whether you’re a PD patient, caregiver, medical professional, advocate, or simply want know more about this complex disease – the Parkinson’s Symposium offers something for everyone. This […]

Parkinson’s Institute and Clinical Center, Retrotope Collaboration to Test RT001 in Progressive Supranuclear Palsy

Parkinson’s Institute and Clinical Center and Retrotope have paired up to explore the therapeutic potential of the investigational agent RT001 in patients with progressive supranuclear palsy (PSP), a type of treatment-resistant Parkinson’s disease. Under Retrotope’s expanded access program for RT001, the institute’s physicians started dosing two PSP patients with the investigational therapy. This pilot study is […]